Suzanne E. Schindler
Impact in
- Psychiatry and Mental health top 0.2%
- Dementia and Cognitive Impairment Research
- Physiology top 0.2%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 172
- Physiology 98
- Alzheimer's disease research and treatments 95
- Clinical Laboratory Practices and Quality Control 2
- Co-authors
- David M. Holtzman (39 shared papers)John C. Morris (94 shared papers)Anne M. Fagan (47 shared papers)Tammie L.S. Benzinger (65 shared papers)Chengjie Xiong (31 shared papers)Brian Andrew Gordon (39 shared papers)Randall John Bateman (33 shared papers)Maia Parsadanian (4 shared papers)
- Journals
- Alzheimer s & Dementia (73 papers)Journal of Alzheimer s Disease (16 papers)Neurology (10 papers)Nature Aging (7 papers)JAMA Neurology (6 papers)
- Partner nations
- United StatesSwedenNetherlands
In The Last Decade
Suzanne E. Schindler
199 papers receiving 8.6k citations
Suzanne E. Schindler's Hit Papers
Peers
Comparison fields: 5 of 122
- Psychiatry and Mental health 4.8k
- Physiology 4.1k
- Neurology 385
- Neurology 185
- Physical Therapy, Sports Therapy and Rehabilitation 80
Countries citing papers authored by Suzanne E. Schindler
This map shows the geographic impact of Suzanne E. Schindler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Schindler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Schindler more than expected).
Fields of papers citing papers by Suzanne E. Schindler
This network shows the impact of papers produced by Suzanne E. Schindler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Schindler. The network helps show where Suzanne E. Schindler may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne E. Schindler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis Hit paper breakdown → | 2019 | 713 |
| 2 | 2004 | 405 | |
| 3 | 2002 | 372 | |
| 4 | 2008 | 327 | |
| 5 | Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests Hit paper breakdown → | 2024 | 311 |
| 6 | Assessment of Racial Disparities in Biomarkers for Alzheimer Disease Hit paper breakdown → | 2019 | 300 |
| 7 | 2005 | 285 | |
| 8 | Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease Hit paper breakdown → | 2023 | 258 |
| 9 | Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care Hit paper breakdown → | 2024 | 241 |
| 10 | 2018 | 222 | |
| 11 | 2018 | 207 | |
| 12 | Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease Hit paper breakdown → | 2024 | 198 |
| 13 | CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease Hit paper breakdown → | 2023 | 181 |
| 14 | Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape Hit paper breakdown → | 2023 | 178 |
| 15 | 2021 | 149 | |
| 16 | Biomarker-based staging of Alzheimer disease: rationale and clinical applications Hit paper breakdown → | 2024 | 129 |
| 17 | CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease Hit paper breakdown → | 2023 | 124 |
| 18 | 2022 | 122 | |
| 19 | Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology Hit paper breakdown → | 2024 | 119 |
| 20 | Donanemab: Appropriate use recommendations Hit paper breakdown → | 2025 | 114 |
About Suzanne E. Schindler
Suzanne E. Schindler is a scholar working on Psychiatry and Mental health, Physiology, Physical Therapy, Sports Therapy and Rehabilitation, Neurology and Cognitive Neuroscience, having authored 226 papers that have together received 8.8k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (172 papers), Alzheimer's disease research and treatments (95 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Older Adults Driving Studies (6 papers), Functional Brain Connectivity Studies (5 papers), Machine Learning in Healthcare (3 papers), COVID-19 and healthcare impacts (3 papers) and Clinical Laboratory Practices and Quality Control (2 papers). The work is most often cited by research in Psychiatry and Mental health (4.8k citations), Physiology (4.1k citations), Neurology (385 citations), Neurology (185 citations) and Physical Therapy, Sports Therapy and Rehabilitation (80 citations). Suzanne E. Schindler has collaborated with scholars based in United States, Sweden and Netherlands. Frequent co-authors include David M. Holtzman, John C. Morris, Anne M. Fagan, Tammie L.S. Benzinger, Chengjie Xiong, Brian Andrew Gordon, Randall John Bateman, Maia Parsadanian, Vitaliy Ovod and Kelly R. Bales. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, Neurology, Nature Aging and JAMA Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.